Short answer · Medically reviewed summary · Last updated: 2026-05-08
Familial Partial Lipodystrophy (FPLD) is a group of rare genetic disorders characterized by the selective loss of subcutaneous adipose tissue, often accompanied by metabolic complications like insulin resistance. It is most commonly referred to as Familial Partial Lipodystrophy, but it is also frequently classified by its specific genetic subtype, such as the Dunnigan-type (FPLD2). What are the common synonyms for Familial Partial Lipodystrophy? Medical literature uses several names for Familial Partial Lipodystrophy, often depending on the specific genetic mutation involved.
Familial Partial Lipodystrophy synonyms
Other names for Familial Partial Lipodystrophy: synonyms, acronyms and related terms used by doctors and patients.
Familial Partial Lipodystrophy (FPLD) is a group of rare genetic disorders characterized by the selective loss of subcutaneous adipose tissue, often accompanied by metabolic complications like insulin resistance. It is most commonly referred to as Familial Partial Lipodystrophy, but it is also frequently classified by its specific genetic subtype, such as the Dunnigan-type (FPLD2).
What are the common synonyms for Familial Partial Lipodystrophy?
Medical literature uses several names for Familial Partial Lipodystrophy, often depending on the specific genetic mutation involved. Historically, the most prominent form was known as Dunnigan-type lipodystrophy. Other terms you may encounter in older records or international journals include:
- Kobberling-type lipodystrophy (FPLD1)
- Dunnigan-type familial partial lipodystrophy (FPLD2)
- Familial lipodystrophy of the limbs-trunk type
- Lipodystrophy, familial partial
- Laminopathies (a broader category including FPLD2)
Why does Familial Partial Lipodystrophy have so many names?
The naming of Familial Partial Lipodystrophy has evolved as genetic research identified specific causative genes. Early descriptions were based solely on physical appearance and clinical presentation (the "phenotype"). As researchers discovered that mutations in the LMNA, PPARG, and PLIN1 genes cause different clinical variations, the terminology shifted toward genetic classification to improve diagnostic precision.
How is Familial Partial Lipodystrophy classified in medical systems?
To ensure consistency, major medical databases use standardized codes to track Familial Partial Lipodystrophy. These identifiers are essential for medical billing and clinical research:
- Orphanet: ORPHA:538 (Familial partial lipodystrophy)
- OMIM: #151660 (Dunnigan-type is the primary entry for FPLD2)
- ICD-10/11: Classified under E88.1 (Lipodystrophy, not elsewhere classified)
Which name is currently preferred by clinicians?
Most geneticists and endocrinologists now prefer using Familial Partial Lipodystrophy followed by the specific genetic subtype (e.g., FPLD2) to guide treatment plans. Our DiseaseMaps.org community, which currently includes 27 members with this condition, emphasizes using these precise genetic designations to help patients connect with others who share their specific mutation type.
Next steps
- Consult an endocrinologist or a clinical geneticist to confirm your specific subtype.
- Review your medical records for the terms listed above to ensure your history is accurately documented.
- Join the 27 members of the DiseaseMaps.org community to share experiences and peer support.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases (GARD) Information Center: Familial partial lipodystrophy.
- Orphanet: Familial partial lipodystrophy (ORPHA:538).
- OMIM (Online Mendelian Inheritance in Man): Entry #151660.
- PubMed: Contemporary reviews on the classification of lipodystrophies.
